AVITA Medical (RCEL) Shares Outstanding (2018 - 2025)

AVITA Medical's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $30.6 million for Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 16.0% year-over-year to $30.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.6 million (up 16.0% YoY) and the FY2025 annual result came in at $30.6 million, up 16.0% from the prior year.
• Shares Outstanding (Entity) was $30.6 million for Q4 2025 at AVITA Medical, roughly flat from $30.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $30.6 million in Q4 2025 and bottomed at $24.8 million in Q1 2021.
• A 5-year average of $26.0 million and a median of $25.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) gained 17.1% — and 2022, when it increased 0.42%.
• AVITA Medical's Shares Outstanding (Entity) stood at $24.9 million in 2021, then advanced by 1.13% to $25.2 million in 2022, then rose by 1.88% to $25.7 million in 2023, then increased by 2.62% to $26.4 million in 2024, then gained by 16.0% to $30.6 million in 2025.
• Business Quant data shows RCEL's Shares Outstanding (Entity) at $30.6 million in Q4 2025, $30.5 million in Q3 2025, and $26.6 million in Q2 2025.